liver injury

Prescription pain drugs that contain acetaminophen -- among the most-prescribed drugs in the U.S.

-- will get a black-box label warning of liver-injury risk and a 325 mg limit on acetaminophen dose.

NASHVILLE, Tenn., Dec. 30, 2010 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has implemented a recall of 6 lots of Acetadote® (acetylcysteine) Injection, the Company's injectable treatment to prevent or lessen liver injury after ingestion of a potentially toxic quantity of acetaminophen.

Cumberland informed the U.S. Food and Drug Administration (FDA) of its plans to voluntarily recall these lots of Acetadote as a precautionary measure based on observed particulate matter found in a very small number of vials.

Bodybuilding.com and FDA notified healthcare professionals and patients of a nationwide and international recall of all lots and expiration dates of 65 dietary supplement products that were sold through the Company's website, www.bodybuilding.com.

RIDGEWOOD, N.J. (MedPage Today) -- Acetaminophen leads the list of drugs implicated in liver damage requiring transplantation, along with greater requirements for dialysis and life support, but antiepileptics remain the most lethal.